Signaling Pathways Involved in 5-FU Drug Resistance in Cancer

Fahima Danesh Pouya1, Yousef Rasmi1,2, Mohadeseh Nemati1

  • 1Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Cancer Investigation
|March 23, 2022
PubMed

Insights

5-fluorouracil resistance in cancer can be overcome by combination therapies. This study explores how 5-fluorouracil interacts with key signaling pathways like JAK/STAT to reverse drug resistance.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • 5-fluorouracil (5-FU) is a cornerstone anti-metabolite chemotherapy agent.
  • Drug resistance significantly limits 5-FU's efficacy in treating various cancers.
  • Mechanisms of resistance involve altered signaling pathways and enzyme expression.

Purpose of the Study:

  • To investigate the role of 5-FU in specific cancer signaling pathways.
  • To understand how combination therapies can overcome 5-FU resistance.
  • To elucidate the molecular mechanisms underlying 5-FU's effectiveness and resistance.

Main Methods:

  • Review of existing literature on 5-FU resistance mechanisms.
  • Analysis of signaling pathways including JAK/STAT, Wnt, Notch, NF-κB, and hedgehog.
  • Discussion of combination therapy strategies.

Main Results:

  • Activation of specific signaling pathways contributes to 5-FU resistance.
  • Combination treatments can restore cancer cell sensitivity to 5-FU.
  • Understanding pathway interactions is key to overcoming resistance.

Conclusions:

  • Targeting or modulating pathways like JAK/STAT, Wnt, Notch, NF-κB, and hedgehog can enhance 5-FU therapy.
  • Combination strategies offer a promising approach to reverse 5-FU drug resistance.
  • Further research into these interactions may lead to improved cancer treatment protocols.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K